SCHEMBL5774543

SCHEMBL5774543

Cc1nc(Cl)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.48
ADORA3 P0DMS8 1/20 0.48
ADORA2A P29274 1/20 0.48
KDM4E B2RXH2 7/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 2/20 0.46
POLB P06746 2/20 0.46
PKM P14618 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 4/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
CDC7 O00311 2/20 0.40
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5772706 0.88 MEN1 (0.40) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL5775897 0.88 MEN1 (0.45) ADORA3KDM4EALDH1A1MEN1KMT2A
SCHEMBL5773374 0.87 MGAM (0.45) ADORA3CDC7
SCHEMBL5772074 0.85 RAD51 (0.41) ADORA1ADORA2AKDM4EALDH1A1MEN1
SCHEMBL5776767 0.84 KDM4E (0.47) ADORA1ADORA2AKDM4EALDH1A1MEN1
SCHEMBL5771482 0.84 KDM4E (0.47) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5775603 0.84 ADORA3 (0.50) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL5773790 0.82 KDM4E (0.48) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL5772874 0.82 KDM4E (0.47) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL5772572 0.82 KMO (0.43) KMT2AMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
EP-1003744-B1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS PFIZER PROD INC (US) 2005-06-01 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
US-6187778-B1 EATING AND CARDIOVASCULAR DISORDERS PFIZER INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed